MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1055-9965.epi-25-2052

Медицинская библиотека · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026

Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer.

Chen Shuai, Kerlikowske Karla, Su Yu-Ru, Hubbard Rebecca A, Gard Charlotte C, Tice Jeffrey A, Sprague Brian L, Ahern Thomas P, Miglioretti Diana L

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Machine learning enables complex risk prediction models, but comparative performance with statistical approaches remains context-dependent. We compared statistical and machine learning models for predicting advanced breast cancer risk.

METHODS

Using data from 968,178 women (40-74 years) undergoing 2,796,459 annual or 812,126 biennial screening mammograms (2005-2019) in the Breast Cancer Surveillance Consortium, we cross-validated models predicting advanced breast cancer within 12 months (annual) or 24 months (biennial) following screening. Models included conventional logistic regression, regularized regressions [least absolute shrinkage and selection operator (LASSO), elastic net], and machine learning methods (random forests, gradient boosting), considering a modest number of clinical and demographic predictors. Performance was assessed using calibration and area under the receiver operating characteristic curve (AUC).

RESULTS

Discrimination was similar across models (AUC 0.677-0.690). Calibration differences were more pronounced. Regularized regressions achieved the most favorable calibration overall and across racial and ethnic groups, with an AUC of 0.689 [95% confidence interval (CI), 0.676-0.701]. Gradient boosting showed a comparable AUC but suboptimal calibration (calibration slope 1.12; 95% CI, 1.04-1.20). Conventional logistic regression had a slightly lower AUC (0.683; 95% CI, 0.671-0.696) and a calibration slope of 0.90 (95% CI, 0.83-0.96). Regression-based approaches were generally well calibrated across racial and ethnic groups (expected-to-observed event ratio 0.96-1.03; calibration intercept -0.03 to 0.04), with some subgroup deviations in calibration slopes (<1).

CONCLUSIONS

For predicting advanced breast cancers, regularized regression demonstrated similar discrimination and generally more favorable calibration than other approaches.

IMPACT: In settings with rare outcomes and low-dimensional features, regularized regression may offer a practical balance between performance and interpretability.

Для цитирования: Chen Shuai, Kerlikowske Karla, Su Yu-Ru, Hubbard Rebecca A, Gard Charlotte C, Tice Jeffrey A, Sprague Brian L, Ahern Thomas P, Miglioretti Diana L. Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancer.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2026. DOI: 10.1158/1055-9965.epi-25-2052.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.